High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Name: High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant
Published: 2017
License: Public Domain

City of Hope Medical Center · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

acute leukemia, chronic lymphocytic leukemia/small lymphocytic lymphoma, chronic myelogenous leukemia, bcr-abl1 positive, diffuse large b-cell lymphoma, follicular lymphoma, graft versus host disease, hodgkin lymphoma, mantle cell lymphoma, marginal zone lymphoma, myelodysplastic syndrome, myeloproliferative neoplasm, recurrent acute myeloid leukemia with myelodysplasia-related changes

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 861290
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.